To view or add a comment, sign in #DYK 58 million people with commercial insurance are eligible for GLP-1 therapies, based on current FDA approvals
Each skin type is different, and its reaction will vary
While BPC-157, TB-500, KPV, and GHK-Cu injections have not been studied for safety and efficacy in large-scale human clinical trials, some risks may be hypothesized from their mechanisms of action
Nobody falls for his talk either, since everybody in town hates him and see him for the pathetic lowlife he really is
On semaglutide or when doing keto, youll want to ensure youre getting adequate dietary protein (about .7 grams per pound of body weight, especially if you exercise), consuming enough electrolytes, and drinking plenty of water
Im Mayank Maheshwari, Morgan Stanleys Asia Energy analyst